HighTower Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.28M Sell
47,414
-1,421
-3% -$120K ﹤0.01% 1340
2026
Q1
$4.08M Sell
48,835
-40,213
-45% -$3.3M ﹤0.01% 1304
2025
Q4
$8.16M Sell
89,048
-85
-0.1% -$8.14K 0.01% 951
2025
Q3
$8.45M Buy
89,133
+1,621
+2% +$153K 0.01% 921
2025
Q2
$9.17M Sell
87,512
-274
-0.3% -$26K 0.01% 837
2025
Q1
$7.76M Sell
87,786
-7,289
-8% -$748K 0.01% 868
2024
Q4
$9.12M Buy
95,075
+4,370
+5% +$407K 0.01% 787
2024
Q3
$7.42M Sell
90,705
-19,840
-18% -$1.53M 0.01% 872
2024
Q2
$9.54M Buy
110,545
+21,842
+25% +$1.76M 0.01% 747
2024
Q1
$7.23M Buy
88,703
+596
+0.7% +$46.5K 0.01% 818
2023
Q4
$5.84M Buy
88,107
+1,167
+1% +$80.9K 0.01% 903
2023
Q3
$6.37M Buy
86,940
+340
+0.4% +$23K 0.01% 820
2023
Q2
$5.47M Buy
86,600
+1,040
+1% +$60.3K 0.01% 861
2023
Q1
$5.03M Buy
85,560
+843
+1% +$51.2K 0.01% 856
2022
Q4
$5.22M Buy
84,717
+1,330
+2% +$89.4K 0.01% 832
2022
Q3
$5.6M Buy
83,387
+245
+0.3% +$15.5K 0.02% 753
2022
Q2
$5.1M Buy
83,142
+584
+0.7% +$37.4K 0.01% 810
2022
Q1
$5.57M Buy
82,558
+1,029
+1% +$55.6K 0.01% 836
2021
Q4
$3.61M Sell
81,529
-3,137
-4% -$183K 0.01% 1064
2021
Q3
$5.48M Buy
84,666
+726
+0.9% +$50.4K 0.01% 784
2021
Q2
$6.76M Buy
83,940
+543
+0.7% +$41.4K 0.02% 679
2021
Q1
$5.67M Buy
83,397
+202
+0.2% +$15.9K 0.02% 696
2020
Q4
$5.8M Sell
83,195
-21
-0% -$1.31K 0.02% 546
2020
Q3
$4.27M Sell
83,216
-376
-0.4% -$20.7K 0.02% 605
2020
Q2
$4.91M Sell
83,592
-947
-1% -$52.4K 0.03% 518
2020
Q1
$4.28M Buy
84,539
+468
+0.6% +$31.1K 0.03% 495
2019
Q4
$6.23M Buy
84,071
+227
+0.3% +$14.2K 0.04% 469
2019
Q3
$4.79M Sell
83,844
-4,662
-5% -$309K 0.03% 568
2019
Q2
$5.79M Sell
88,506
-41,317
-32% -$2.88M 0.03% 501
2019
Q1
$9.6M Buy
129,823
+1,980
+2% +$139K 0.06% 308
2018
Q4
$7.62M Sell
127,843
-4,301
-3% -$347K 0.06% 336
2018
Q3
$12.5M Buy
132,144
+419
+0.3% +$36.1K 0.09% 246
2018
Q2
$9.89M Buy
131,725
+3,101
+2% +$223K 0.08% 278
2018
Q1
$7.79M Buy
128,624
+4,031
+3% +$218K 0.07% 324
2017
Q4
$5.81M Sell
124,593
-485
-0.4% -$24K 0.05% 424
2017
Q3
$6.33M Sell
125,078
-31,038
-20% -$1.44M 0.05% 392
2017
Q2
$7.78M Buy
156,116
+8,029
+5% +$376K 0.07% 317
2017
Q1
$6.29M Sell
148,087
-22,707
-13% -$1M 0.06% 360
2016
Q4
$6.92M Sell
170,794
-5
-0% -$193 0.08% 277
2016
Q3
$6.46M Buy
170,799
+731
+0.4% +$23.2K 0.07% 284
2016
Q2
$5.17M Hold
170,068
0.07% 317
2016
Q1
$4.2M Sell
170,068
-141
-0.1% -$3.02K 0.01% 451
2015
Q4
$4.27M Sell
170,209
-119,859
-41% -$3.68M 0.05% 376
2015
Q3
$8.57M Buy
+290,068
New +$9.12M 0.11% 195

Other funds holding HQY

HighTower Advisors's HQY Position: Q2 2026 in Review

HighTower Advisors reduced its HealthEquity (HQY) stake by 2.9% in Q2 2026, selling an estimated $120K and leaving 47,414 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1340.

HighTower Advisors first reported a position in HQY in Q3 2015 and has held it in 44 quarters since. The position peaked at $12.5M in Q3 2018. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • HighTower Advisors held 47,414 shares of HealthEquity worth $4.28M as of Q2 2026.
  • HighTower Advisors sold 1,421 HealthEquity shares in Q2 2026, an estimated $120K.
  • HealthEquity made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1340 holding.
  • HighTower Advisors first reported a position in HealthEquity in Q3 2015 and has held it in 44 quarters since.
  • HighTower Advisors's HealthEquity position peaked at $12.5M in Q3 2018.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.